ANDA & 505(b)(2) Strategy Consulting

ANDA & 505(b)(2) Strategy Consulting

demo-attachment-1408-Group-46

iVakil IP offer strategic consulting related to the drug development process for ANDA and 505(b)(2) program for US market.

iVakil IP offer strategic consulting related to the drug development process for ANDA and 505(b)(2) program for US market.

iVakil scientific team includes prominent pharmaceutical product development leaders from industry and academia. Their years of hands-on experience with every facet of pharmaceutical research and development enables our pharma company clients’ to bring new products to the market quickly and efficiently.

demo-attachment-261-Group-56
demo-attachment-607-Rectangle-37
httptest.inventivearc.comwp-contentuploads202009Trademark.jpg (3)
demo-attachment-606-Group-43

We Offer Client

  • Identification of new 505(b)(2) idea with business and scientific justification based on client requirement.

  • Generation of proof of concept with IP rights

  • Generation of business case with timeline to bring product into market.

  • Evaluating licensing partners on behalf of clients.

  • Providing regulatory advise to clients for 505(b)(2) and complex generics product.

  • Providing early market entry opportunity advise to client for ANDA products based on competitive intelligence.

We work with
touch of experience

demo-attachment-261-Group-56
About us